Parente P - Search Results

1

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.

Kwan EM, Spain L, Anton A, Gan CL, Garrett L, Chang D, Liow E, Bennett C, Zheng T, Yu J, Dai C, Du P, Jia S, Fettke H, Abou-Seif C, Kothari G, Shaw M, Parente P, Pezaro C, Tran B, Siva S, Azad AA. Kwan EM, et al. Among authors: parente p. Eur Urol. 2022 Mar;81(3):253-262. doi: 10.1016/j.eururo.2021.08.011. Epub 2021 Sep 4. Eur Urol. 2022. PMID: 34493414 Clinical Trial.

2

Malignant melanoma mimicking acute leukemia.

Tran B, Fong C, Tong M, Hosking P, Schwarer AP, Parente P. Tran B, et al. Among authors: parente p. J Clin Oncol. 2009 Aug 20;27(24):e62-4. doi: 10.1200/JCO.2009.21.9956. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487374 No abstract available.

3

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: the Australian perspective.

Parente P, Parnis F, Gurney H. Parente P, et al. Asia Pac J Clin Oncol. 2012 Mar;8(1):31-42. doi: 10.1111/j.1743-7563.2011.01506.x. Asia Pac J Clin Oncol. 2012. PMID: 22369442 Review.

4

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer.

Parente P, Parnis F, Gurney H. Parente P, et al. Asia Pac J Clin Oncol. 2014 Sep;10(3):205-15. doi: 10.1111/ajco.12193. Epub 2014 Apr 3. Asia Pac J Clin Oncol. 2014. PMID: 24750803 Review.

5

'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.

Lomax AJ, Parente P, Gilfillan C, Livingston PM, Davis ID, Pezaro C. Lomax AJ, et al. Among authors: parente p. Intern Med J. 2016 Feb;46(2):141-8. doi: 10.1111/imj.12731. Intern Med J. 2016. PMID: 25732203 Review.

6

Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.

Tiu C, Pezaro C, Davis ID, Grossmann M, Parente P. Tiu C, et al. Among authors: parente p. Asia Pac J Clin Oncol. 2015 Jun;11(2):190-4. doi: 10.1111/ajco.12348. Epub 2015 Apr 9. Asia Pac J Clin Oncol. 2015. PMID: 25855890

7

Docetaxel in very elderly men with metastatic castration-resistant prostate cancer.

Wong HL, Lok SW, Wong S, Parente P, Rosenthal M. Wong HL, et al. Among authors: parente p. Prostate Int. 2015 Jun;3(2):42-6. doi: 10.1016/j.prnil.2015.03.003. Epub 2015 Mar 19. Prostate Int. 2015. PMID: 26157766 Free PMC article.

8

Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.

Wong HL, Lee B, Field K, Lomax A, Tacey M, Shapiro J, McKendrick J, Zimet A, Yip D, Nott L, Jennens R, Richardson G, Tie J, Kosmider S, Parente P, Lim L, Cooray P, Tran B, Desai J, Wong R, Gibbs P. Wong HL, et al. Among authors: parente p. Clin Colorectal Cancer. 2016 Jun;15(2):e9-e15. doi: 10.1016/j.clcc.2016.02.007. Epub 2016 Feb 13. Clin Colorectal Cancer. 2016. PMID: 26968236

9

Author reply 'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.

Lomax AJ, Parente P, Gilfillan C, Livingston PM, Davis ID, Pezaro C. Lomax AJ, et al. Among authors: parente p. Intern Med J. 2016 Apr;46(4):507-8. doi: 10.1111/imj.13035. Intern Med J. 2016. PMID: 27062210 No abstract available.

10

Posterior reversible encephalopathy syndrome mimicking brain metastases in a patient with metastatic transitional cell carcinoma.

Wong K, Lee M, Davis ID, Parente P, Mckendrick J, Pezaro C. Wong K, et al. Among authors: parente p. Asia Pac J Clin Oncol. 2017 Oct;13(5):e534-e536. doi: 10.1111/ajco.12510. Epub 2016 Oct 11. Asia Pac J Clin Oncol. 2017. PMID: 27726296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters